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Abstract 
Despite the worldwide prevalence of bacterial vaginosis (BV), its etiology is still unknown. 
Although BV has been associated with the presence of biofilm, the ability of BV-associated 
bacteria to form biofilms is still largely unknown. Here, we isolated 30 BV-associated species 
and characterized their virulence, using an in vitro biofilm model. Our data suggests that G. 
vaginalis had the highest virulence potential, as defined by higher initial adhesion and 
cytotoxicity of epithelial cells, as well as the greater propensity to form a biofilm. Interestingly, 
we also demonstrated that most of the BV-associated bacteria had a tendency to grown as 
biofilms. 
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Introduction 
Bacterial vaginosis (BV) is one of the most common vaginal disorders of women, of reproductive 
age; it has been associated to an abnormal pregnancy, inflammatory pelvic disease and 
increased risk of acquiring sexual transmitted diseases [1]. The high prevalence, high relapse 
rate, and associated complications, make BV of paramount importance. Yet, despite its impact 
on womens health, little is known about the pathogenesis of BV. Due to the detection of multiple 
bacterial species in BV patients, many researchers consider it a polymicrobial infection [2]. 
Importantly,  Swidsinski et al. first reported the presence of a multi-species biofilm, mainly 
formed by Gardnerella vaginalis, in the vaginal epithelium of women with BV [3]. However, while 
some attention is now focused on G. vaginalis biofilms, the role of the other BV-associated 
bacteria has been somewhat neglected. To better understand BV etiology, the isolation and 
culture of BV-associated bacteria is necessary, in order to determine their virulence potential. 
We recently demonstrated that, despite having a lower ability to adhere and displace lactobacilli 
from an inert surface, Atopobium vaginae and Fusobacterium nucleatum were able to stimulate 
and enhance biofilm formation by G. vaginalis [4]. This suggested that some species might have 
an important role in BV as secondary pathogens. However, current knowledge about the 
specific role of most BV-associated bacteria is still scarce since functional microbiological 
studies often use very limited number of species [5]. Here, in a first approach to determine the 
role of BV-associated bacteria in biofilm formation, we isolated 30 bacterial species, from BV 
patients, and evaluate their virulence potential using an in vitro biofilm model. We characterized 
their ability to adhere to epithelial cells and to induce cytotoxic changes, as well as to grow as 
biofilms. Their susceptibility, to antibiotics commonly used in BV treatment, was also 
determined. 
 
Methods 
Vaginal Samples, Bacteria Isolation and Identification 
Vaginal samples were obtained from volunteer women after informed consent as approved by 
the Minho University Institutional Review Board (SECVS 003-2013). Samples were analyzed by 
microscopy after Gram staining and BV diagnosis was based on Nugent criteria [6]. BV positive 
vaginal samples were used for bacteria isolation in anaerobic conditions as previously 
described [7]. Briefly, bacteria were isolated using Columbia Agar supplemented with 5% horse 
blood (CBA) and incubated at 37°C in the presence of 5%, 10% CO2 or in anaerobic conditions 
generated by AnaeroGenTM (Oxoid). Plates were incubated for up to one week. Where 
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possible, bacteria were identified by DNA sequencing of the 16S rRNA gene. However, due to 
high homology in Staphylococcus spp and Corynebacterium spp, their identification was 
performed by DNA sequencing of rpoB gene. Additionally, biochemical tests were also 
performed for organisms where DNA sequencing could not identify the isolate. More details are 
listed in supplementary table 1. 
 
Initial Adhesion to Epithelial Cells and Cytotoxicity Assays 
Initial adhesion to epithelial cells was performed as previously optimized [8]. Briefly, bacterial 
suspensions, grown in supplemented brain heart infusion broth (sBHI) containing 2% (w/w) 
gelatin, 0.5% yeast extract, 0.1% starch and 0.1% glucose, were resuspended in DMEM 
medium to 1×10
8 
CFU.mL
-1 
and were added to a monolayer of HeLa cells, for 30 min at 37ºC, in 
anaerobic conditions. After washing the non-adherent bacteria, cells were fixed with methanol 
and adhesion was microscopically quantified and expressed as the average number of bacteria 
per epithelial cell. Cytotoxicity assays were performed with a bacterial concentration of 2.9×10
7 
CFU.mL
-1 
with an incubation period of 3 H [5]. Cytotoxicity was scored as follows: 0, no 
difference between the test and the control; 1, 25% of the cells were rounded; 2, 25–50% of the 
cells were rounded; 3, 50% of the cells were rounded; 4, 50% cells were rounded, with partial 
disruption of the monolayer and 5, complete disruption/absence of the monolayer. Twenty fields 
of view were acquired per experiment and three independent experiments, with technical 
duplicates, were performed for each analysis. 
 
Biofilm Formation and Quantification 
Biofilms were grown in 9 different culture media: Luria broth (LB); LBG (LB supplemented with 
0.25% (w/v) glucose); de Man-Rogosa and Sharpe agar (MRS); MRSG; Tryptic Soy broth 
(TSB); TSBG; sBHI (BHI supplemented with 2% (w/w) gelatin, 0.5% (w/w) yeast extract, and 
0.1% (w/w) starch); sBHIG and sBHIF (sBHI supplemented with 10% (v/v) fetal bovine serum). 
Biofilms were qualitatively quantified with safranin staining [5]. Subsequently, the intrinsic ability 
to form biofilms was quantified as described by Harwich et al. [9] using the 3 media that 
promoted the greatest biofilm growth, ensuring that one was common to all isolates. The biofilm 
formation index (BFI) was defined as the average number of bacteria grown as biofilms, in the 3 
selected media. The data analysis was based on at least 3 independent experiments. 
 
Antibiotic Susceptibility  
The susceptibility of the isolated bacteria to the 3 most common antibiotics used for BV 
treatment, namely metronidazole (MD), tinidazole (TZ) and clindamycin (CM), was evaluated by 
determining the minimum inhibitory concentration (MIC). 
 
Statistical Analysis  
Independent unpaired data were analyzed using student’s t-test and statistical package for the 
social sciences (SPSS) software (IBM, Chicago, IL, USA). A p-value less than 0.05 was 
considered significant. 
 
Results  
Vaginal samples were obtained from 40 Portuguese women, between 18 and 40 years old. BV 
was found in 11 women and these samples were selected for bacterial isolation. 30 distinct 
bacterial species were isolated and 1 strain, per species, was selected for further studies (table 
1).  
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Table 1 | Initial adhesion, cytotoxicity score and biofilm formation index (BFI) of the vaginal 
bacteria isolated from Portuguese women diagnosed with BV. Experiments were repeated three 
times. 
Bacteria Bacteria/HeLa cell   
(Mean ± SD) 
Cytotoxicity 
score 
a
 
BFI 
b  
 
(Mean ± SD)
 
Antibiotics – MIC
c
 range 
(µg.mL
-1
) 
    
MD TZ CM 
Gardnerella vaginalis  13.54 ± 2.83 4 87.60 ± 6.26 > 128 32 - 64 < 0.01 
Streptococcus agalactiae  2.01 ± 0.49 3 53.36 ± 12.64 > 128 > 128 > 128 
Streptococcus anginosus  1.74 ± 0.30 3 64.90 ± 20.13 > 128 > 128 > 128 
Staphylococcus epidermidis  1.18 ± 0.12 3 49.30 ± 12.79 > 128 > 128 > 128 
Shigella spp  1.06 ± 0.19 3 27.71 ± 6.64 > 128 > 128 > 128 
Staphylococcus haemolyticus  0.71 ± 0.06 3 44.30 ± 7.00 > 128 > 128 0.125 – 0.06 
Klebsiella/Enterobacter  4.24 ± 0.39 2 25.17 ± 4.72 > 128 > 128 > 128 
Corynebacterium tuscaniense  1.77 ± 0.34 2 82.34 ± 8.78 > 128 > 128 > 128 
Corynebacterium amycolatum  1.64 ± 0.37 2 71.22 ± 17.52 > 128 > 128 > 128 
Aerococcus christensenii  1.51 ± 0.08 2 74.27 ± 14.18 > 128 > 128 0.01 – 0.06 
Staphylococcus hominis  1.21 ± 0.12 2 80.27 ± 11.62 > 128 > 128 > 128 
Actinomyces turicensis  1.18 ± 0.00 2 80.80 ± 5.49 > 128 > 128 < 0.01 
Lactobacillus vaginalis  0.95 ± 0.10 2 48.59 ± 8.27 > 128 > 128 2 -4 
Bifidobacterium longum  0.84 ± 0.15 2 54.67 ± 7.28 > 128 > 128 < 0.01 
Staphylococcus fleuretti  0.84 ± 0.20 2 57.84 ± 12.23 > 128 > 128 4 
Gemella haemolysans  0.80 ± 0.43 2 53.51 ± 3.70 > 128 > 128 > 128 
Bacillus firmus  0.78 ± 0.23 2 23.91 ± 5.20 > 128 > 128 64 - 128 
Actinomyces neuii  0.65 ± 0.10 2 72.42 ± 9.18 > 128 > 128 0.25 – 0.125 
Enterococcus faecalis  0.42 ± 0.06 2 78.91 ± 10.50 > 128 > 128 64 – 128 
Brevibacterium ravenspurgense  0.36 ± 0.04 2 52.71 ± 12.75 > 128 > 128 > 128 
Propionibacterium acnes  0.12 ± 0.08 2 58.56 ± 6.47 > 128 > 128 0.01 – 0.06 
Mycoplasma hominis  12.60 ± 5.43 1 73.84 ± 21.01 > 128 > 128 0.125 
Corynebacterium tuberculostearicum  5.78 ± 0.69 1 56.52 ± 6.29 > 128 > 128 64 - 128 
Staphylococcus warnerii  5.16 ± 0.29 1 50.08 ± 11.09 > 128 > 128 0.25 
Staphylococcus saprophyticus  4.35 ± 0.72 1 59.50 ± 24.31 > 128 > 128 > 128 
Nosocomiicoccus ampullae  3.80 ± 0.07 1 69.23 ± 7.79 > 128 > 128 4 
Staphylococcus simulans  1.81 ± 0.02 1 64.73 ± 10.89 > 128 > 128 > 128 
Escherichia coli  1.20 ± 0.12 1 23.56 ± 6,96 > 128 > 128 > 128 
Breviobacterium mcbrellneri  0.56 ± 0.14 1 75.09 ± 7.67 > 128 > 128 64 - 128 
Micrococcus spp 0.16 ± 0.09 1 65.65 ± 6.02 > 128 > 128 0.06 – 0.25 
Note. 
a 
Cytotoxicity was scored as follows: 0, no difference between the experimental well and the control; 1, < 25 % cells were rounded; 
2, 25-50 % cells were rounded; 3, >50 % cells were rounded; 4, > 50% were rounded, with partial disruption of the monolayer; 5, 
complete disruption/absence of the monolayer 
b
 The index of intrinsic capacity for biofilm formation was calculated using the average of the 3 growth media with higher biofilm growth, 
including a common media. 
c 
MIC, Minimum inhibitory concentration.
 
 
 
Some of the isolated species had never been associated with BV cases before, such as 
Brevibacterium ravenspurgence, Corynebacterium tuscaniense, Nosocomiicoccus ampullae, 
Staphylococcus warneri, Staphylococcus fleuretti and Bacillus firmus (supplementary table 1).  
 
We first quantified the ability of the selected isolates to adhere to a monolayer of HeLa epithelial 
cells. Interestingly, there were dramatic differences in adhesion between G. vaginalis and 
Mycoplasma hominis relative to the remaining BV isolates, with G. vaginalis demonstrating 
higher initial adhesion ability. The cytotoxic effect on these epithelial cells was also evaluated, 
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since it is an important trait in BV [5]. Of note, we observed that the majority of bacteria (80%) 
had very low cytotoxicity, with G. vaginalis showing the highest cytotoxicity score.  
 
In order to determine the optimal medium, for in vitro biofilm formation, all isolates were initially 
cultured anaerobically, using 9 different growth media. As expected, our qualitative analysis 
showed different biofilm-forming capability, by the different species, and this was highly 
dependent on the media used (supplementary table 2). Hence, to quantitatively determine each 
species tendency to grow as biofilm, we determined the BFI. Our results showed that G. 
vaginalis was the bacteria with highest BFI, when compared to the others isolates. Surprisingly, 
our results also demonstrated that most BV-associated bacteria, such as M. hominis, 
Staphylococcus hominis, Brevibacterium mcbrellneri and Enterococcus faecalis, also showed 
significant biofilm-forming capability. 
 
Finally, in vitro susceptibility of isolates to MD, TZ and CM was evaluated by determining the 
MIC. All bacteria tested were resistant to MD and TZ. Conversely, the number of bacteria 
resistant to CM was only 67%. Our results, were not surprising since an increasing incidence of 
resistance  associated  with  conventional  antibiotic therapy, for species that have been 
associated with BV, has previously been demonstrated [10].  
 
Discussion 
BV is often considered a polymicrobial infection due to the frequent identification of multiple 
bacterial species associated with this condition. However, the limitations associated with 
classical microbiological culture techniques have inadvertently affected the ability of scientists to 
understand the etiology of this clinical condition. As a polymicrobial infection, different species 
might have different roles in the initiation and progression of BV. Since BV is associated with 
biofilm formation, it has been proposed that G. vaginalis might compete with vaginal 
Lactobacillus spp. and enable other BV-associated bacteria to be incorporated and grow within 
the biofilm [5]. Theoretically, an early colonizer would contribute to initial adhesion to the 
epithelium, while late and/or secondary colonizers could contribute to biofilm maturation. This is 
a process that has been extensively studied in oral biofilms [11] and we recently demonstrated 
this principle, in BV, by using mixed biofilms of G. vaginalis, Mobiluncus mulieris, A. vaginae, 
Prevotella bivia and F. nucleatum [4]. Being the most prevalent bacterial species of BV-
associated biofilms, most studies have tended to focus on G. vaginalis. To highlight its 
contribution to pathogenicity, biofilm formation has already been shown to increase tolerance of 
G. vaginalis to external stresses [12], including tolerance to antibiotics, with implications for high 
recurrence and relapse rates in those persons predisposed to BV [13]. Prior to this work,very 
few studies have investigated biofilm formation  of other BV-associated bacteria [1]. To better 
understand the virulence potential of the multiple species found in BV, we used an in vitro 
biofilm model, and tested the virulence potential of 30 different species isolated from BV 
patients.  
Since initial adhesion is the first step in biofilm formation [14], we first aimed to assess which 
species were likely to be most prevalent in the early stages of BV development. Interestingly, 
only G. vaginalis and M. hominis adhered avidly to HeLa cells, suggesting that these two 
species could play an important role as early colonizers in BV. However, M. hominis revealed 
very low cytotoxicity to HeLa cells, contrary to G. vaginalis. Furthermore, an important aspect 
that undermines the possible role of M. hominis as the main agent of BV is related to the 
relative prevalence of both species in BV, since M. hominis is found less often than G. vaginalis 
[15]. All other strains had very low adhesion and cytotoxicity levels. Interestingly, we did not find 
any correlation between initial adhesion and cytotoxicity, suggesting that cytotoxicity is not an 
entirely density dependent process. 
 
We then determined the intrinsic capability for biofilm formation, as described first by Harwich et 
al. [9]. Since we were unable to identify a single growth media that was optimal for all species, 
we defined the BFI as the average of bacterial growth as biofilm, using 3 distinct growth media. 
With this approach, we tried to minimize the limitations of in vitro biofilm formation, since not all 
factors found in vivo, are reproducible in vitro. Despite this limitation, only 3 species showed 
lower ability to grow as biofilm (BFI < 30%) in contrast to all the remaining tested species.  
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Finally, we detected high levels of resistance against common antibiotics used to treat BV, in all 
isolated species. Bacteria were more susceptible to CM than to MD or TZ, which was expected, 
based on previous studies that reported a high resistance to metronidazole [10]. Without an 
identified etiological agent, BV treatment has been based on empiricism, which can contribute 
to the increase in antimicrobial resistance [14]. Importantly, high antibiotic resistance acquisition 
rates have been associated with multi-species biofilms [14], and this could explain the similar 
and high resistance levels found in our study. 
 
In conclusion, this study  sheds new light on the possible roles of many bacteria associated with 
BV and, for the first time, directly compares their biofilm forming ability. Even though our data 
provides strong evidence that G. vaginalis could be the main colonizer in BV, our results also 
demonstrated that other BV-associated species have a high capacity to grow as biofilm. Yet to 
be determined is whether these bacteria opportunistically join the mixed-species biofilms, often 
found in BV, with no consequence to the outcome of the disease, or if these species can 
interact synergistically with G. vaginalis, as shown before for A. vaginae and F. nucleatum, 
enhancing biofilm forming ability, and therefore contributing to the high relapse rates found in 
BV. 
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Supplements 
 
Supplementary Table 1 | Identification of BV isolates. The partial sequences of 16S rRNA or rpoB coding genes obtained after DNA sequencing were 
analysed using Basic Local Alignment Search Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) for bacteria identification. 
Bacteria Gene Sequence 
Length 
Query Coverage 
(%) 
Maximum Identity (%) Accession Number Biochemical tests* 
Actinomyces neuii UM067  16S rRNA 740 99 99 NR_042429.1; NR_042428.1 G, +/- 
Actinomyces turicensis UM066  16S rRNA 734 99 99 NR_037020.1 G -/- 
Aerococcus christensenii UM137  16S rRNA 735 99 99 NR_044929.1 G -/- 
Bacillus firmus UM034  16S rRNA 699 100 98 NR_025842.1 G 
Bifidobacterium longum UM062  16S rRNA 702 100 99 NR_043437.1; NR_074744.1  G -/- 
Brevibacterium ravenspurgense UM066  16S rRNA 722 99 99 NR 044398.1 G +/+ 
Brevibacterium spp UM137  16S rRNA 722 99 98 NR_026299.1; NR_025375.1 G +/+ 
Corynebacterium amycolatum UM065 rpoB 384 98 99 HE586300.1; AY492241.1;HE586299.1 G +/- 
Corynebacterium tuberculostearicum UM137 rpoB 398 98 94 AY581869,1 G +/- 
Corynebacterium tuscaniense UM137 rpoB 400 95 94 FJ416377.1 G +/- 
Enterococcus faecalis UM035 16S rRNA 745 100 99 NR_074637.1; NR_040789.1  G 
Escherichia coli UM056 16S rRNA 723 99 99 NR_026331.1; NR_026332.1; NR_027549.1; 
NR_024570.1 
g, +/-, L, I, LMX 
Gardnerella vaginalis UM224 16S rRNA 723 99 99 NR_074227.1; NR_044694.1  Gg, -/- 
Gemella haemolysans UM034 16S rRNA 732 99 99 NR_025903.1  G  
Klebsiella/Enterobacter UM062 16S rRNA 740 99 99 NR_074729.1; NR_025635.1; NR_036794.1; 
NR_037084.1; NR_074913.1; NR_041750.1; 
NR_024643.1; NR_024640.1  
g, +/- 
Lactobacillus vaginalis UM062 16S rRNA 760 99 99 NR 041796.1 G, -/- 
Micrococcus spp UM067 16S rRNA 712 99 99 NR 075062.1; NR 037113.1; NR 044365.1 G, +/- 
Mycoplasma hominis UM054 16S rRNA 733 99 99 NR_041881.1  g 
Nosocomiicoccus ampullae UM121 16S rRNA 629 99 99 NR 044444.1 G, +/+ 
Propionibacterium acnes UM034 16S rRNA 725 99 99 NR_074675.1; NR_040847.1  G 
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Shigella spp UM137 16S rRNA 743 99 99 NR_074894.1; NR_026331.1; NR_027549.1; 
NR_074902.1; NR_026332.1; NR_074892.1; 
NR_074893.1; NR_074891.1; NR_074882.1; 
NR_024570.1 
g, +/-, L, I, lmx 
Sreptococcus agalactiae UM035 16S rRNA 329 98 99 NR_040821.1; NR_036918.1; NR_037101.1 G 
Staphylococcus epidermidis UM066 rpoB 845 99 98 CP000029.1;AE015929.1 G, +/- 
Staphylococcus fleuretti UM121 rpoB 780 95 90 GC222236.1 G, +/+ 
Staphylococcus haemolyticus UM066 rpoB 847 99 100 AP006716.1 G, +/- 
Staphylococcus hominis UM224 rpoB 679 80 98 EF173661.1 G, +/- 
Staphylococcus saprophyticus UM121 rpoB 832 100 99 AP008934.1 G, +/- 
Staphylococcus simulans UM059 rpoB 755 99 99 NR 036906.1 G, +/- 
Staphylococcus warnerii UM224 rpoB 488 99 100 AF325895.1 G, +/- 
Streptococcus anginosus UM241 16S rRNA 756 99 99 NR 041722.1 G, -/- 
*Results obtained for the biochemical tested performed: Gram-positive (G), Gram-negative (g), catalase and oxidase-positive (+/+), catalase and oxidase- negative (-/-), catalase-positive and oxidase-negative (+/-), lactose 
fermentation positive (L), indole-positive (I), fluorescence under UV light of LMX medium (LMX), absence of fluorescence under UV light of LMX medium (lmx). 
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Supplementary Table 2 | Qualitative analysis of biofilm-forming ability of bacterial vaginosis 1 
isolates. The ability of isolates to form biofilm was tested in 9 different growth media commonly 2 
used in biofilm formation assays.  3 
 
Media 
Strains LB LBG MRS MRSG TSB TSBG sBHI sBHIG sBHIF 
Actinomyces neuii UM067 +- +- +- +- +- +++ +- +- +- 
Actinomyces turicensis UM066 - - - ++ ++ +++ ++ ++ +- 
Aerococcus christensenii UM137 - +- - - - +++ ++ +- +- 
Bacillus firmus UM034 +- +- +- +- +- +- +- +- +- 
Bifidobacterium longum UM062 +- +- +- +- +- +- +- +- ++ 
Brevibacterium ravenspurgense UM066 +- +- - - - - ++ +- +- 
Brevibacterium mcbrellneri UM137 ++ ++ ++ ++ ++ +++ +++ ++ +- 
Corynebacterium tuscaniense UM137 +- +- ++ +- ++ +++ ++ ++ +- 
Corynebacterium amycolatum UM065 +- +- +- +- +- +- ++ ++ +- 
Corynebacterium tuberculostearicum UM137 +- +- +- +- +- +- +- +- +- 
Enterococcus faecalis UM035 +- ++ +- +- +- ++ ++ +- +- 
Escherichia coli UM056 +- +- +- +- +- +- +- +- +- 
Gardnerella vaginalis UM224 - - +- +- +- +- ++ +++ ++ 
Gemella haemolysans UM034 +- +- +- +- +- +- +- +- +- 
Klebsiella/Enterobacter UM062 +- +- +- ++ +- +- +- +- +- 
Lactobacillus vaginalis UM062 - - - - - - +- +- +- 
Micrococcus spp. UM067 +- +- +- +- +- ++ ++ ++ +- 
Mycoplasma hominis UM054 - +- - - - +++ ++ +- +- 
Nosocomiicoccus ampullae UM121 +- +- +- +- ++ ++ ++ ++ ++ 
Propionibacterium acnes UM034 ++ ++ - - - - ++ +- ++ 
Streptococcus agalactiae UM035 - - - - ++ ++ +- ++ ++ 
Shigella spp UM137 +- +- +- +- +- +- +- +- +- 
Staphylococcus epidermidis UM066 +- ++ ++ ++ ++ ++ +- ++ ++ 
Staphylococcus fleuretti UM121 +- +- +- ++ +- +- +- ++ +- 
Staphylococcus haemolyticus UM066 +- +- +- +- ++ +- ++ +- ++ 
Staphylococcus hominis UM224 +- +- +- ++ +- ++ ++ ++ +- 
Staphylococcus simulans UM059 +- +- +- +- +- ++ +- +- +- 
Staphylococcus saprophyticus UM121 +- +- +- +- ++ +++ +- ++ +- 
Staphylococcus warnerii UM224 +- ++ +- +- +- +- +- ++ +- 
Streptococcus anginosus UM241 +- +- +- +- +- +- ++ ++ ++ 
Note. Initially,  the  biofilm  formation  ability  was  screened,  qualitatively,  using  all  9  growth media presented in this table, including  a 4 
common media to all isolates - sBHI media, as one of the nutrient-rich laboratory medium. These set of media, was selected, due to 5 
being the most common growth media used before in biofilm forming assays. Biofilms obtained were scored from (-) no biofilm formed, 6 
(+-) formed medium or good biofilm in all tests, (++) good biofilm formation in all tests, (+++) strong biofilm formation in all tests.  7 
Abbreviations: LB, luria broth; LBG, LB supplemented with 0.25% (w/v) glucose; MRS, de man-rogosa and sharpe agar; MRSG, MRS 8 
supplemented with 0.25% (w/v) glucose; TSB, tryptic soy broth; TSBG, TSB supplemented with 0.25% (w/v) glucose; sBHI, BHI 9 
supplemented brain heart infusion broth supplemented with 2% (w/w) gelatin, 0.5% (w/w) yeast extract, and 0.1% (w/w) starch; sBHIG, 10 
sBHI supplemented with 0.25% (w/v) glucose ; sBHIF, sBHI supplemented with 10% (v/v) fetal bovine serum.  11 
  12 
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